iastolic heart failure is a frequent complication of hypertension 1 and is preceded by changes in left ventricular (LV) filling characteristics that reflect decreased compliance of the ventricular wall. In hypertension, changes in LV diastolic function occur even in the absence of ventricular hypertrophy and are associated with increased morbidity and mortality.
D
iastolic heart failure is a frequent complication of hypertension 1 and is preceded by changes in left ventricular (LV) filling characteristics that reflect decreased compliance of the ventricular wall. In hypertension, changes in LV diastolic function occur even in the absence of ventricular hypertrophy and are associated with increased morbidity and mortality. 2 Therefore, early identification of hypertension-related LV filling changes is important to forestall subsequent cardiac deterioration leading to diastolic heart failure. 3 Sensitivity of conventional echocardiography in detection of early changes in LV filling properties is limited, 4 whereas pulsed tissueDoppler imaging (TDI) with measurement of myocardial velocities at several segments of the LV wall allows more sensitive and reproducible 5 detection of LV diastolic impairment. Many factors beyond the blood pressure-related cardiac workload could contribute to the development of diastolic abnormalities of the hypertensive heart. These factors include ageing, 6 obesity, 7 hyperglycemia with insulin resistance, 8 and a prothrombotic state. 9 Moreover, dietary factors such as caloric, 10 electrolyte, 11 and ethanol intake 12 might affect LV diastolic properties. Chronic alcoholic subjects are at risk for the development of nonischemic dilated cardiomyopathy and heavy ethanol consumption (>90 g/d of ethanol; ≈7-8 standard drinks per day) is associated with impairment of LV systolic function. Animal studies have demonstrated that longterm ethanol exposure produces a variety of tissue and cellular changes. These changes can impair cardiomyocyte function leading to heart failure and include either necrosis or apoptosis of myocytes, mitochondrial and sarcoplasmic reticulum dysfunction, changes in isoforms of myofilament proteins, and defective intracellular calcium transport. 13 Previous studies conducted with conventional echocardiography indicated that, in addition to the well-known untoward effects on LV systolic function, LV filling properties are impaired in chronic asymptomatic alcoholics. 14, 15 However, information on the association of moderate (≤14 Abstract-Ethanol consumption is associated with left ventricular dysfunction in heavy ethanol drinkers. The effect of moderate ethanol intake on left ventricular function in hypertension, however, is unknown. We investigated the relationship between ethanol consumption and cardiac changes in nonalcoholic hypertensive patients. In 335 patients with primary hypertension, we assessed daily ethanol consumption by questionnaires that combined evaluation of recent and lifetime ethanol exposure and examined cardiac structure and function by echocardiography. Patients with abnormal liver tests, previous cardiovascular events, left ventricular ejection fraction <50%, and creatinine clearance <30 mL/min 1.72 m 2 were excluded. Left ventricular hypertrophy was found in 21% of hypertensive patients and diastolic dysfunction was detected in 50% by tissue-Doppler imaging. Ethanol consumption was comparable in hypertensive patients with and without left ventricular hypertrophy, whereas patients with left ventricular diastolic dysfunction had significantly greater consumption than patients with normal ventricular filling. Left atrial diameter, e′ wave velocity, e′/a′ ratio, and E/e′ ratio changed progressively with increasing levels of ethanol consumption, and prevalence of left ventricular diastolic dysfunction increased with a change that became statistically significant in patients consuming 20 g/d of ethanol or more. The e′ wave velocity was inversely correlated with ethanol consumption, and multivariate logistic regression indicated that ethanol consumption predicted diastolic dysfunction independently of age, body mass index, blood pressure, insulin sensitivity, and left ventricular mass index. In conclusion, ethanol consumption is independently associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients and might contribute to development of diastolic heart failure. (Hypertension. 2016;68:1208-1216. DOI: drinks/wk for men and 7 drinks/wk for women) ethanol consumption with LV diastolic properties in hypertension is not available. The aim of this study was to investigate the relationship between moderate ethanol intake and markers of LV diastolic dysfunction obtained at TDI in nonalcoholic patients with primary hypertension free of cardiovascular complications and with a preserved LV ejection fraction.
Methods

Study Population
Three hundred and thirty-five patients with grade 1 to 2 primary hypertension were included in a cross-sectional study. Patients were consecutively recruited at our University clinic where patients had direct access. Blood pressure was measured by an automated device (Omron M6; OMRON Healthcare Co, Kyoto, Japan) using an appropriately sized cuff after each subject had been supine for 15 minutes, and the average of 3 readings was recorded. 16 Diagnosis of hypertension was based on repeated blood pressure measurements obtained in at least 3 separate visits, according to current guidelines. 16 Predefined exclusion criteria were age <18 years or >80 years; pregnancy or use of estrogens; body mass index (BMI) >35 kg/m 2 ; history of alcohol addiction as defined by the Alcohol Use Disorders Identification Test (AUDIT-C) questionnaire 17 ; binge drinking (>8 drinks/d) and average daily ethanol intake of ≥80 g/d 18, 19 ; abnormal liver tests; secondary hypertension; refractory hypertension 20 ; impaired LV systolic function (ejection fraction <50%); 24-hour creatinine clearance (glomerular filtration rate) <30 mL/min/1.73 m 2 ; and history of acute illness, stroke, transitory ischemic attack, coronary heart, cardiac valve, or other types of heart disease, and peripheral artery disease. All patients were white and were representative of the hypertensive population of the geographical area. 21 Secondary causes of hypertension were excluded in all patients according to established guidelines 16 and as previously reported 22 (online-only Data Supplement). Average daily ethanol intake (g/d) was estimated by questionnaires that were collected by trained personnel and combined evaluation of recent 23 and lifetime 24 ethanol exposure (Table S1 in the online-only Data Supplement), as previously reported. 25 Participants were classified into 4 categories according to their average daily ethanol consumption: nondrinkers and drinkers of 1 to 19, 20 to 39, and 40 to 79 g/d. Patients were classified as smokers if they had smoked for at least 5 years and ≤1 year before the study. One hundred and twenty-nine (39%) of the 335 hypertensive patients had never been treated with antihypertensive drugs. The remaining 206 patients were previously treated with angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists (62%), calcium-channel antagonists (45%), diuretics (38%), β receptor antagonists (30%), and α receptor antagonists (10%). Before the study, patients ate a standard diet for 7 days to maintain a sodium intake of ≈150 mmol/d that was checked with measurement of 24-hour urinary sodium excretion. The study was performed in accordance with the principles of the Declaration of Helsinki and received approval from the institutional review board. Informed consent was obtained from all patients.
Laboratory Measurements
Venous blood was collected in the morning after a 12-hour fast with the patients in the sitting position. Plasma was separated and frozen at −80 °C before assay. Plasma glucose was measured using the glucoseoxidase method, plasma lipids were assayed enzymatically, uric acid levels were determined by the uricase-peroxidase system, and plasma insulin by radioimmunoassay. 26 The Homeostatic Model Assessment (HOMA) index was calculated as an index of insulin sensitivity. 27 Glomerular filtration rate was assessed by duplicate measurement of 24-hour creatinine clearance and normalized for body surface area.
Echocardiography
Cardiac ultrasound examination was performed as described previously 28 by the same experienced investigator who was unaware of the patients' clinical and laboratory characteristics. LV mass index was normalized for body height, with a cutoff value of 50 g/m 2.7 for men and 47 g/m 2.7 for women used to define LV hypertrophy. 29 Diastolic dysfunction was defined on the basis of early diastolic velocities (e′) of septal and lateral myocardial portions lower than the age-specific cutoff values (<10 cm/s in patients younger than 55 years, <9 cm/s in patients from 55 to 65 years, <8 cm/s in patients aged >65 years) 28 (online-only Data Supplement).
Statistical Analysis
Sample size was calculated to provide a statistical power >90% in the detection of a 20% difference in average ethanol intake between hypertensive patients with or without LV diastolic dysfunction as detected by TDI, with a probability of type I error <5%. Values are reported as mean±SD for normally distributed variables and as median and interquartile ranges for variables with skewed distribution. Normality of distribution was assessed with the Kolmogorov-Smirnov test, and variables with skewed distribution were analyzed after logarithmic transformation. Pearson χ 2 test was used to compare frequency distributions. Student t test was used for comparisons between 2 independent groups. Analysis of variance was used for comparisons of >2 groups with adjustment for covariates and Bonferroni correction. Relationships between continuously distributed variables were examined through linear regression analysis, with correlation expressed by Pearson correlation coefficient. A multivariate logistic regression model was used to identify which variables were independently associated with LV diastolic dysfunction as detected by TDI that was identified as the dependent variable, whereas independent variables were included in the model according to the level of association found in univariate analysis. Multicollinearity was assessed by calculation for each variable of the logistic model of a variance inflation factor. A value of P<5% was considered to indicate statistical significance. Data analyses were performed using Stata 12.1 (StataCorp LP, College Station, TX).
Results
Three hundred and thirty-five hypertensive patients (age 52±14 years; 178 men and 157 women; 129 treatment naive) were enrolled between January 2010 and December 2015. Clinical characteristics, laboratory tests, and echocardiographic variables of hypertensive patients are reported in Table 1 , where hypertensive patients are also divided according to the presence or absence of LV hypertrophy. Prevalence of LV hypertrophy in hypertensive patients was 21% (15% concentric and 6% eccentric). Patients with LV hypertrophy were older and had higher BMI, systolic blood pressure, HOMA index, plasma triglycerides, and uric acid than patients with normal LV mass. In patients with LV hypertrophy, diastolic function was worse than in patients with normal LV mass as demonstrated by significantly greater left atrial diameter, lower E/A ratio, e′ velocity, and e′/a′ ratio, and higher isovolumic relaxation time and E/e′ ratio. None of the patients had focal defects of LV wall motion. Frequency of smoking and average daily ethanol consumption were comparable in patients with or without LV hypertrophy.
At TDI, LV diastolic dysfunction was detected in 167 (50%) of 335 hypertensive patients, and their characteristics are summarized in Table 2 . In all patients, the pattern of diastolic dysfunction was abnormal relaxation, whereas no pseudonormal or restrictive filling patterns were found. LV diastolic dysfunction was associated with older age, greater BMI, blood pressure, frequency of diabetes mellitus, plasma levels of glucose, HOMA index, LV mass index, and relative wall thickness, but not with smoking habit, glomerular Values are expressed as mean±SD. Median and interquartile range in parenthesis are shown for variables with skewed distribution. Left ventricular diastolic dysfunction was defined at tissue-Doppler imaging on the basis of e′ velocities lower than the age-specific cutoff values. Variables with skewed distribution were analyzed after logarithmic transformation. Comparisons were done by the Student t test for unpaired observations. Pearson χfiltration rate, and urinary sodium excretion. Average daily ethanol consumption in patients with LV diastolic dysfunction was 3-fold that of patients with normal LV filling properties. Table 3 reports clinical characteristics, laboratory tests, and echocardiographic variables of hypertensive patients who were grouped according to 4 different levels of ethanol consumption. Among hypertensive patients, 172 patients (51%; 39% men and 61% women) were nondrinkers, 85 (25%; 60% men and 40% women) reported daily ethanol consumption from 1 to 19 g/d, 55 (16%; 73% men and 27% women) from 20 to 39 g/d, and 23 (7%; 78% men and 22% women) from 40 to 79 g/d. Increasing ethanol intake was significantly and progressively associated with older age; male sex; higher plasma glucose, uric acid, and liver enzyme levels; greater left atrial diameter and E/e′ ratio; and lower e′ velocity and e′/a′ ratio. Although there was a trend of LV mass index to increase with increasing ethanol intake, prevalence of LV hypertrophy did not differ among patients with different levels of daily ethanol consumption (Figure) . Conversely, prevalence of LV diastolic dysfunction increased progressively with increasing ethanol consumption from 41% to 87% with a change that became statistically significant in patients consuming ≥20 g/d of ethanol (Figure) . Greater prevalence of LV diastolic dysfunction with increasing ethanol consumption was observed also when men (P<0.001) and women (P=0.021) were considered separately. Because almost all drinkers consumed different types of alcoholic drinks, we could not separate their respective relevance in the association with diastolic dysfunction.
Correlation analysis indicated that LV mass index was significantly and directly related with age (r=0.356; P<0.001), BMI (r=0.435; P<0.001), systolic blood pressure (r=0.294; P<0.001), and uric acid levels (r=0.234; P=0.013). All variables of LV diastolic function were significantly correlated with age, BMI, HOMA index, LV mass index, and relative wall thickness and, with the exception of the E/e′ ratio, with glomerular filtration rate (Table 4) . Daily ethanol consumption was directly and significantly correlated with left atrial diameter and E/e′ ratio and inversely with e′ velocity and e′/a′ ratio.
Patients in the heaviest drinking group were older and had a trend to higher systolic blood pressure, HOMA index, and LV mass index that might have contributed to LV diastolic dysfunction in these patients (Table 3) . We therefore assessed independence of associations in a multivariate logistic regression analysis that included LV diastolic dysfunction as detected by TDI as the dependent variable and age, BMI, systolic blood pressure, ethanol consumption, HOMA index, uric acid, and LV mass index as independent variables (Table 5) . Analysis demonstrated that age, BMI, systolic blood pressure, and ethanol consumption were independent predictors of LV diastolic dysfunction. In these analysis, multicollinearity of variables was excluded by calculation of variance inflation factors for each variable included in the model (all <2). The same multivariate logistic model was applied to 129 treatment-naive patients ( Table S2 ) similarly reporting that ethanol consumption was independent predictor of LV diastolic dysfunction.
Discussion
Robust epidemiological evidence indicates that heavy ethanol consumption impairs cardiac function. The effects of moderate ethanol intake on the heart, however, are debated. Because of the impact that ethanol consumption might have in the early stages of hypertensive heart disease, we investigated the relationship of moderate ethanol intake with cardiac structure and function in nonalcoholic hypertensive patients free of cardiovascular complications. Our findings indicate that increasing daily ethanol consumption within the limit of 80 g/d is not related to LV hypertrophy but is associated with progressive worsening of LV diastolic function. This effect becomes significant with levels of ethanol consumption of ≥20 g/d. Moreover, daily ethanol consumption is a predictor of LV diastolic dysfunction as detected at TDI independently of age, BMI, blood pressure, insulin resistance, and LV mass index. Thus, moderate ethanol intake contributes to early cardiac functional changes in hypertensive patients without affecting LV structure, an effect that is possibly related to direct toxic effects of ethanol to cardiomyocyte function leading to myocardial stiffening. 13 It is well known that alcohol abuse is associated with increased prevalence of hypertension 30 and progressive impairment of LV systolic function, leading to dilated cardiomyopathy and congestive heart failure. 31 Previous studies conducted with conventional echocardiographic technique reported also an association between ethanol consumption and impaired LV diastolic properties in asymptomatic chronic alcoholics. 14, 15, 32 However, information on the effects of moderate ethanol consumption on LV diastolic filling is limited. In a recent report, 4466 elderly subjects from the ARIC study (Atherosclerosis Risk in Communities) 12 were categorized into 4 groups according to their ethanol intake (nondrinkers and drinkers of ≤7, ≥7-13, and ≥14 drinks per week). In these subjects, increasing ethanol consumption was associated with larger left atrial diameter and higher E/e′ ratio, suggesting LV diastolic dysfunction. Although this study reported associations between ethanol intake and subclinical LV abnormalities in both sexes, women seemed more susceptible than men to the toxic effects of ethanol.
In hypertension, diastolic dysfunction is commonly associated with LV hypertrophy, but it is also frequently detected in patients with normal LV mass in whom it might anticipate diastolic heart failure. With use of TDI, LV diastolic dysfunction was detected in half of our hypertensive patients and was associated with older age, greater BMI, blood pressure, insulin resistance, LV mass index, and relative wall thickness. These patients were either nondrinkers or habitual consumers of moderate amounts of ethanol and had no history of alcohol abuse or binge drinking. The present results demonstrate for the first time that in these patients daily ethanol consumption is significantly associated with progressive worsening of LV diastolic function and predicts diastolic dysfunction independently of other confounders. Despite a trend to increase LV mass index with increasing ethanol, prevalence of LV hypertrophy in our patients' categories did not change significantly. Moreover, we could not detect any significant difference between sexes in the association of ethanol consumption with diastolic dysfunction, most likely because women were largely underrepresented in the category with the highest ethanol consumption. Values are expressed as mean±SD. Median and interquartile range in parenthesis are shown for variables with skewed distribution. Comparisons were done by one-way ANOVA. A indicates late-wave transmitral diastolic velocity; ALT, alanine aminotransferase; AST, aspartate aminotransferase; E, early-wave transmitral diastolic velocity; e′, early-diastolic velocity of septal and lateral myocardial portions at tissue Doppler imaging; e′/a′, early-to-late diastolic velocity ratio at tissue Doppler imaging; E/e′, E-wave transmitral velocity to early-diastolic velocity at tissue Doppler imaging ratio; γ-GT, γ-glutamyl transferase; HOMA, homeostatic model assessment; and LV, left ventricular. The present findings might appear in contrast with those of previous epidemiological studies 33 and meta-analyses 34 that have reported a favorable effect of moderate ethanol consumption on lowering the incidence of heart failure. It must be noticed, however, that the majority of patients who developed heart failure in those studies had atherosclerotic coronary artery disease 35 and LV systolic dysfunction. Therefore, in addition to an amount of ethanol that in those studies was different from the present study, other mechanisms related to ethanol intake that differ from those directly caused by ethanol to the myocardium might have played an important role. 35 These mechanisms may include beneficial effects of ethanol on some atherosclerotic risk factors (eg, increased high-density lipoprotein cholesterol and fibrinolysis and decreased plasma viscosity and fibrinogen concentration, platelet aggregation, lipoprotein[a], inflammatory molecules, and oxidative stress) 13 or neurohormonal mechanisms (reninangiotensin system and adiponectin). 36 In the present study, patients with LV systolic dysfunction were excluded and those with coronary artery disease because we wanted to specifically focus on LV diastolic function. Moreover, an increasing body of evidence supports the existence of multiple mechanisms that might account for direct toxicity of ethanol to the cardiomyocyte. These mechanisms include cell loss resulting from necrosis or apoptosis, mitochondrial and sarcoplasmic reticulum dysfunction, changes in isoforms of myofilament proteins, and defective intracellular calcium transport. 13 Limitations of this study should be highlighted. This is a cross-sectional study, and as such, it does not permit to obtain conclusive evidence on a causal relationship between ethanol intake and LV diastolic dysfunction, although the dose dependence of association and independence from other major confounders might suggest so. Also, because of use of a clinic sample, our observation should be generalized to a broader context with caution. Furthermore, because of inclusion of a substantial proportion of patients who were treated with antihypertensive agents, effects on LV diastolic filling properties of these agents could represent an important confounder. For this reason, we conducted a separate analysis of treatmentnaive patients reporting the same results as in the overall study population (Table S2) . Finally, it is important to consider that additional conditions acting as possible cofactors for myocardial stiffening and LV diastolic impairment such as blood pressure variability as assessed by 24-hour monitoring, additional dietary habits, and physical inactivity were not included in our analysis.
The strengths of this study include its large size, the ability to control for major determinants of LV diastolic function after exclusion of patients with impaired LV systolic function or other cardiovascular complications, the use of TDI for definition of diastolic dysfunction, and, mostly relevant, the accurate methodology used for definition of daily ethanol consumption 18 that provided the best assessment of both recent and lifetime ethanol exposure.
Perspectives
Impaired LV diastolic function is found in a substantial proportion of hypertensive patients and might anticipate diastolic heart failure. Implementation of treatment strategies that prevent functional deterioration of the hypertensive heart requires identification of factors that, in addition to the blood pressure-related cardiac workload, contribute to LV diastolic changes. This study, the first conducted in nonalcoholic hypertensive patients free of cardiovascular complications, has examined the relationship of moderate ethanol consumption with LV diastolic function. Results indicate that increasing daily ethanol consumption within the limit of 80 g/d is associated with progressive worsening of LV diastolic function, suggesting an independent contribution of moderate ethanol intake to LV diastolic dysfunction. Therefore, even within a moderate range of daily consumption, ethanol restriction might be beneficial to the heart of hypertensive patients. This hypothesis should be tested in appropriately designed intervention studies. 
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